Your browser doesn't support javascript.
loading
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer.
Wang, Xiao-Shan; Bai, Yi-Feng; Verma, Vivek; Yu, Rui-Lian; Tian, Wei; Ao, Rui; Deng, Ying; Zhu, Xue-Qiang; Liu, Hao; Pan, Hai-Xia; Yang, Lan; Bai, Han-Song; Luo, Xing; Guo, Yan; Zhou, Ming-Xiu; Sun, Yue-Mei; Zhang, Zi-Can; Li, Si-Min; Cheng, Xue; Tan, Bang-Xian; Han, Liang-Fu; Liu, Ying-Yi; Zhang, Kai; Zeng, Fan-Xin; Jia, Lin; Hao, Xin-Bao; Wang, You-Yu; Feng, Gang; Xie, Ke; Lu, You; Zeng, Ming.
Afiliación
  • Wang XS; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Bai YF; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Verma V; Department of Radiation Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
  • Yu RL; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Tian W; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Ao R; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Deng Y; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Zhu XQ; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Liu H; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Pan HX; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Yang L; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Bai HS; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Luo X; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Guo Y; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Zhou MX; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Sun YM; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China.
  • Zhang ZC; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China.
  • Li SM; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Cheng X; Southwest Medical University, Luzhou City, Sichuan Province, China.
  • Tan BX; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Han LF; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
  • Liu YY; Boao Evergrande International Hospital, Qionghai, Hainan Province, China.
  • Zhang K; Cancer Center, Sichuan Friendship Hospital, Chengdu, Sichuan Province, China.
  • Zeng FX; Cancer Center, Ziyang People's Hospital, Ziyang, Sichuan Province, China.
  • Jia L; Dazhou Central Hospital, Dazhou, Sichuan Province, China.
  • Hao XB; Third Hospital of Mianyang (Sichuan Mental Health Center), Mianyang, Sichuan Province, China.
  • Wang YY; Cancer Center, First Affiliated Hospital of Hainan Medical College, National Drug Clinical Trial Institute, Haikou, Hainan Province, China.
  • Feng G; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Xie K; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Lu Y; Cancer Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
  • Zeng M; Cancer Center, West China Hospital, Chengdu, Sichuan Province, China.
J Natl Cancer Inst ; 115(6): 742-748, 2023 06 08.
Article en En | MEDLINE | ID: mdl-35094066
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Aspecto: Ethics Límite: Humans Idioma: En Revista: J Natl Cancer Inst Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Aspecto: Ethics Límite: Humans Idioma: En Revista: J Natl Cancer Inst Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos